2020 AWARD RECIPIENTS
ICI WORLDWIDE STARTUP COMPETITION
Autus Valve Technologies, Inc.
(posted January 8, 2021) In December 2020, the Jon DeHaan Foundation was once again proud to support ICI Worldwide Startup Competition. ICI’s competition provides participants the opportunity for clinical and commercial validation as well as international exposure. Ten companies presented virtually over two days to a panel of distinguished judges from the field.
Two winners were announced, Autus Valve Technologies, Inc. and VDyne, Inc. Autus Valve Technologies, Inc. has developed a biomimetic balloon expandable valve for the treatment of pediatric congenital valve disease. VDyne’s transcatheter tricuspid valve replacement system is indicated for the percutaneous reduction of symptomatic tricuspid valve regurgitation.
The winners will share the Foundation’s US$ 150,000 Award for Innovation in Cardiology. Says Tom DeHaan, “Cardiovascular disease is the number one cause of death in the world and accounts for one in every six dollars spent on healthcare in the USA. So, it is a target-rich environment for those looking to improve the lives of millions. By seeking out and publicly recognizing the most promising medical advances at an early stage and then financially assisting these innovators during a business phase typically beset with financial vulnerability we believe it is possible to help ensure the most promising developments survive R&D and achieve mainstream implementation on an accelerated basis. This opens up the prospect of a “two-fer” by not only improving patient outcomes but also simultaneously bending the overall healthcare cost curve downward.”
Watch ICI Meeting on demand for free until the end of February.
TCT SHARK TANK
On Sight Medical
(now UltraSight Medical)
(posted November 5, 2020) The Jon DeHaan Foundation was pleased to once again sponsor Cardiovascular Research Foundation’s TCT Shark Tank. The competition is designed to award the technology most likely to disrupt and transform the field of interventional cardiology. This year’s virtual event took place on October 15 and 16. Six companies competed for the Foundation’s $200 000 Award for Innovation in Cardiology and the prestigious recognition from TCT.
After a tough competition featuring several innovative devices, On Sight Medical was announced the winner. On Sight is developing AI-based software for cardiac ultrasound guidance, detection, and analysis. The company is anticipating that the portable ultrasound they are developing will be useful in telehealth and in remote regions around the world. They hope that by improving access to ultrasound tools more healthcare professionals will be able to provide preventative cardiac care for their patients.
The Foundation is proud to be able to support On Sight Medical and is grateful for its partnership with CRF. Says Tom DeHaan, “By seeking out and publicly recognizing the most promising medical advances at an early stage and then financially assisting these innovators during a business phase typically beset with financial vulnerability, we believe it is possible to help ensure the most promising developments survive R&D and achieve mainstream implementation on an accelerated basis.”
Since 2018, the Foundation has distributed more than one million dollars in awards through partnerships with organizations like CRF. “The DeHaan Foundation remains committed to its primary mission of supporting cardiovascular disease innovation,” said Robert Schwartz, MD, President of the Jon DeHaan Foundation. “The partnership with the Cardiovascular Research Foundation and TCT is an ideal collaboration to further this goal. We are pleased to continue these efforts with the Shark Tank sessions at TCT Connect.”
Watch TCT Shark Tank through TCTConnect. They are providing all of their content on-demand for free until December 3, 2020.